Castle Rock Wealth Management, LLC Dexcom Inc Transaction History

Castle Rock Wealth Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$67.99 - $132.89 $74,109 - $144,850	-1,090 Closed	0 $0
Q1 2022 Apr 25, 2022	SELL	$94.08 - $130.2 $102,359 - $141,657	-1,088 Reduced 49.95%	1,090 $536,000
Q4 2021 Feb 02, 2022	SELL	$129.87 - $162.82 $97,272 - $121,952	-749 Reduced 25.59%	2,178 $919,000
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $4,161 - $5,584	39 Added 1.35%	2,927 $1.87 Million
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $8,260 - $11,008	102 Added 3.66%	2,888 $1.44 Million
Q1 2021 Apr 27, 2021	BUY	$84.79 - $104.74 $22,554 - $27,860	266 Added 10.56%	2,786 $1.14 Million
Q4 2020 Jan 29, 2021	BUY	$78.0 - $104.5 $31,044 - $41,591	398 Added 18.76%	2,520 $933,000
Q3 2020 Dec 07, 2020	BUY	$95.51 - $112.95 $39,541 - $46,761	414 Added 24.24%	2,122 $823,000
Q2 2020 Aug 10, 2020	BUY	$62.68 - $105.34 $54,531 - $91,645	870 Added 103.82%	1,708 $755,000
Q1 2020 May 18, 2020	BUY	$47.79 - $75.63 $40,048 - $63,377	838 New	838 $338,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Castle Rock Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Castle Rock Wealth Management, LLC with notifications on news.